ONCOLOGIC OUTCOMES OF GEMCITABINE-DOCETAXEL COMBINATION INTRAVESICAL BLADDER SPARING THERAPY COMPARED TO UPFRONT RADICAL CYSTECTOMY IN BCG-UNRESPONSIVE NON-MUSCLE INVASIVE BLADDER CANCER
Drupad Annapureddy(The University of Texas Southwestern Medical Center), William C. Huang(NYU Langone Health), Ashish M. Kamat(The University of Texas MD Anderson Cancer Center), Stephen Harrington(Queensland University of Technology), M. Roumiguié(Institut universitaire du cancer de Toulouse Oncopole), Yair Lotan(Southwestern Medical Center), Jeffrey T. Howard(The University of Texas Southwestern Medical Center), Michael J. O’Donnell(University of Iowa), Ian M. McElree(Vanderbilt University Medical Center), Seth P. Lerner(Baylor College of Medicine), Peter C. Black(University of British Columbia), Roger Li(Unknown), Gary D. Steinberg(Rush University Medical Center), Jacob Taylor(The University of Texas Southwestern Medical Center), Anna J. Black(University of British Columbia), Pratik Kanabur(Carilion Clinic), Wei Shen Tan, Solomon L. Woldu(The University of Texas Southwestern Medical Center), Vignesh T. Packiam(Rutgers, The State University of New Jersey), Davaro Facundo(Moffitt Cancer Center), Jay D. Raman(Penn State Milton S. Hershey Medical Center), Kendrick Yim(Brigham and Women's Hospital), Mark A. Preston(Brigham and Women's Hospital), Elizabeth Dyer(Penn State Milton S. Hershey Medical Center)
Cited by 1
Related Papers
Impact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant Chemotherapy
|European Urology|2017|793
Pembrolizumab monotherapy for the treatment of high-risk non-muscle-invasive bladder cancer unresponsive to BCG (KEYNOTE-057): an open-label, single-arm, multicentre, phase 2 study
|The Lancet Oncology|2021|532
Epidemiology, diagnosis, preoperative evaluation and prognostic assessment of upper-tract urothelial carcinoma (UTUC)
|World Journal of Urology|2016|471
An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer
|Nature Communications|2021|381